During the past decade, Shah Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shah Associates" #1 sponsor was "Millennium Pharmaceuticals, Inc." with 2 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shah Associates" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Shah Associates" are "Arthritis, Rheumatoid" (1 trials), "Clostridium Infections" (1 trials), "Conscious Sedation" (1 trials), "Coronary Artery Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Shah Associates" in a lesser frequency.

Most popular intervention types in "Shah Associates" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "vedolizumab" (2 trials), "AQUAVAN® (fospropofol disodium) Injection" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials) and "Ibuprofen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shah Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Shah Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Shah Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shah Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".